Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivian Laquer

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
JAAD International|December 6, 2021
Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results of an open-label study evaluating adrenal suppression potentialVivian Laquer, Andrea Nguyen, Nicholas Squittieri, et al.
JAAD Case Reports|April 8, 2020
"Peeling paint" dermatosis in a leukemia patientMargit Juhasz, Vivian Laquer, James Jerkins, et al.
Cutis|July 30, 2010
Sorafenib-associated psoriasiform skin changesVivian Laquer, Nazanin Saedi, Frank Dann, et al.
Dermatology Online Journal|September 21, 2013
Mycobacterium poriferae infection in a psoriasis patient on anti-TNF-α therapyVivian Laquer, Tuan Ta, Tien Nguyen, et al.
Journal of the American Academy of Dermatology|November 21, 2009
Angiogenesis in cutaneous disease: part IAmy Nguyen, Van Hoang, Vivian Laquer, et al.
Journal of the American Academy of Dermatology|November 21, 2009
Angiogenesis in cutaneous disease: part IIVivian Laquer, Van Hoang, Amy Nguyen, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2023
INDIVIDUAL ARTICLE: Management of Prurigo NodularisSarina B Elmariah, Lindsay Tao, Rodrigo Valdes-Rodriguez, et al.
Dermatology Reports|April 29, 2015
Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept StudyChrista Ky, Brian Swasdibutra, Shaadi Khademi, et al.
Dermatology and Therapy|July 18, 2025
The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA)Jennifer Soung, Vivian Laquer, Matthew Zirwas, et al.
Dermatology and Therapy|January 28, 2022
Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in AdolescentsRobert Sidbury, Sady Alpizar, Vivian Laquer, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
JAAD International|December 6, 2021
Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results of an open-label study evaluating adrenal suppression potentialVivian Laquer, Andrea Nguyen, Nicholas Squittieri, et al.
JAAD Case Reports|April 8, 2020
"Peeling paint" dermatosis in a leukemia patientMargit Juhasz, Vivian Laquer, James Jerkins, et al.
Cutis|July 30, 2010
Sorafenib-associated psoriasiform skin changesVivian Laquer, Nazanin Saedi, Frank Dann, et al.
Dermatology Online Journal|September 21, 2013
Mycobacterium poriferae infection in a psoriasis patient on anti-TNF-α therapyVivian Laquer, Tuan Ta, Tien Nguyen, et al.
Journal of the American Academy of Dermatology|November 21, 2009
Angiogenesis in cutaneous disease: part IAmy Nguyen, Van Hoang, Vivian Laquer, et al.
Journal of the American Academy of Dermatology|November 21, 2009
Angiogenesis in cutaneous disease: part IIVivian Laquer, Van Hoang, Amy Nguyen, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2023
INDIVIDUAL ARTICLE: Management of Prurigo NodularisSarina B Elmariah, Lindsay Tao, Rodrigo Valdes-Rodriguez, et al.
Dermatology Reports|April 29, 2015
Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept StudyChrista Ky, Brian Swasdibutra, Shaadi Khademi, et al.
Dermatology and Therapy|July 18, 2025
The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA)Jennifer Soung, Vivian Laquer, Matthew Zirwas, et al.
Dermatology and Therapy|January 28, 2022
Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in AdolescentsRobert Sidbury, Sady Alpizar, Vivian Laquer, et al.
Pageof 3